SEC Form 4 · accession 0001610717-26-000395
Ascendis Pharma A/S · ASND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lars Holtug
Director
Period of report
Sep 2, 2026
Accepted (ET)
Sep 3, 2026 · 4:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001612042
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sep 2, 2026 | S | 236 | $264.1296 | D | 4,000 | D |
Table II — derivative securities
No Table II lines on this filing.